Academic Journal
An aging essential 8: closing the gap between geroscience and the public it serves.
| Τίτλος: | An aging essential 8: closing the gap between geroscience and the public it serves. |
|---|---|
| Συγγραφείς: | Grimolizzi F; Division of Molecular Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. franco.grimolizzi@outlook.it. |
| Πηγή: | Biogerontology [Biogerontology] 2026 Aug 26; Vol. 27 (5). Date of Electronic Publication: 2026 Aug 26. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 100930043 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6768 (Electronic) Linking ISSN: 13895729 NLM ISO Abbreviation: Biogerontology Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Dordrecht ; Boston : Kluwer Academic, c2000- |
| Ιατρικοί όροι (MeSH): | Aging*/physiology , Geroscience*/methods , Longevity*, Humans ; Biomarkers |
| Περίληψη: | Longevity science has advanced faster than the public's capacity to interpret it. Biological age tests, longevity clinics, and consumer wearables now reach millions of people, yet no shared framework exists to tell an individual what those numbers mean or what to do about them. Cardiovascular medicine encountered a comparable problem and resolved it not with a new therapeutic but with a communication instrument: Life's Essential 8, which distilled a contested risk landscape into eight components scored from 0 to 100, and which has since been shown to track biological aging itself. This Perspective argues that geroscience has assembled much of the material for an equivalent instrument, even while the field continues to disagree about foundational questions. Expert panels have converged on which biomarkers are worth tracking as outcomes in aging intervention trials, and have concluded that no single biomarker suffices, which leaves a composite as the only viable path. What has not happened is the translation of that research-level agreement into a public-facing instrument. A candidate structure is proposed, comprising four behavioral and four biological pillars with explicit scoring thresholds, designed for administration by clinicians in primary care rather than by longevity clinics only, and constructed so that seven of the eight components require only a questionnaire, a bedside test, and routine bloods. (© 2026. The Author(s).) |
| Competing Interests: | Declarations. Competing interests: The author declares no competing interests relevant to this work. |
| References: | PLoS Med. 2008 Jan 8;5(1):e12. (PMID: 18184033) PLoS Med. 2018 Dec 31;15(12):e1002718. (PMID: 30596641) Aging (Albany NY). 2018 Apr 18;10(4):573-591. (PMID: 29676998) PNAS Nexus. 2024 Dec 03;3(12):pgae499. (PMID: 39660064) Nat Med. 2024 Feb;30(2):360-372. (PMID: 38355974) Biogerontology. 2024 Feb;25(1):1-8. (PMID: 38206540) Physiotherapy. 2011 Sep;97(3):182-9. (PMID: 21820535) Nat Aging. 2024 Oct;4(10):1372-1383. (PMID: 39285015) Aging Dis. 2024 Jul 15;16(4):1971-1986. (PMID: 38607731) Mech Ageing Dev. 2020 Oct;191:111316. (PMID: 32693105) J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5):. (PMID: 39708300) Cell. 2023 Aug 31;186(18):3758-3775. (PMID: 37657418) Biogerontology. 2025 Jul 1;26(4):138. (PMID: 40591010) Cell. 2023 Jan 19;186(2):243-278. (PMID: 36599349) Circulation. 2022 Aug 2;146(5):e18-e43. (PMID: 35766027) |
| Contributed Indexing: | Keywords: Aging biomarkers; Biological aging; Composite health score; Health equity; Healthy longevity; Primary care; Risk communication |
| Substance Nomenclature: | 0 (Biomarkers) |
| Entry Date(s): | Date Created: 20260826 Date Completed: 20260826 Latest Revision: 20260829 |
| Update Code: | 20260829 |
| PubMed Central ID: | PMC13518415 |
| DOI: | 10.1007/s10522-026-10497-y |
| PMID: | 42645553 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!